Clinical Trial Update: Cardiac Arrhythmia Suppression Trial (CAST) [Phase 3]

View source ↗

Summary

The CAST trial, a Phase 3 cardiac arrhythmia study, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest
• Cardiovascular Diseases
• Coronary Artery Disease
• Heart Diseases
• Myocardial Infarction
• Myocardial Ischemia
• Sudden Cardiac Death
• Ventricular Arrhythmia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED